CIRAD, the French agricultural research and international cooperation organization, has signed the ASEACA project, a new initiative aimed at preventing the risks of zoonotic disease emergence. The signing confirms the project's formal launch and marks CIRAD's latest commitment to research that addresses pathogens before they cross from animals to humans.

The project's stated objective is prevention. Rather than responding to outbreaks after they occur, ASEACA is designed to target the upstream conditions that allow zoonotic pathogens to emerge — a framing that places it squarely within the "One Health" approach CIRAD has promoted across its research portfolio, integrating human, animal and environmental health dimensions.

Zoonotic disease prevention sits at the intersection of several veterinary domains, and the implications differ by sector.

For companion-animal practice, projects of this type rarely change protocols directly, but they reinforce the rationale for routine surveillance of pathogens shared between pets and people. Veterinary clinics remain a sentinel node in the detection chain for zoonotic agents, and research initiatives that map emergence pathways eventually feed back into diagnostic guidance and client communication about risks such as vector-borne and foodborne pathogens.

For food-animal and production systems, the stakes are more direct. Livestock operations — particularly those involving wildlife-livestock interfaces, intensive production, or land-use change at farm margins — are recognized drivers of zoonotic emergence. Research under agreements like ASEACA typically informs biosecurity standards, surveillance frameworks and early-warning tools that shape how producers and herd veterinarians manage contact points between species. The signing signals continued investment in this upstream layer of disease control, which sits ahead of, and reduces pressure on, downstream regulatory response.

For public health, the rationale is straightforward. Most emerging infectious diseases in humans originate in animals, and prevention-focused research reduces the human, animal and economic costs of spillover events. Projects of this scope also carry diplomatic and institutional weight: they formalize cooperation between research organizations and their regional partners, building the surveillance capacity needed to detect unusual pathogen activity early.

ASEACA joins a portfolio of CIRAD-led international projects addressing emerging infectious risks. CIRAD's model pairs European research infrastructure with in-country partners in regions where the animal-human-environment interface is under the greatest pressure — typically in tropical and subtropical zones characterized by dense livestock-wildlife-human contact and accelerating land-use change.

The signing itself is the milestone. It converts a planned initiative into an operational one, with committed partners and a defined prevention mandate. In the weeks ahead, the veterinary and public-health communities will be watching for the project's workplan — which pathogens and which interfaces it prioritizes, what surveillance methods it deploys, and how its findings will reach the clinicians, producers and public-health authorities who act on them. For now, the agreement establishes that the prevention of zoonotic emergence remains a funded, institutional priority for CIRAD and its partners.